These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 3080463

  • 1. Endogenous dopaminergic dysfunction: a novel form of human growth hormone deficiency and short stature.
    Huseman CA, Hassing JM, Sibilia MG.
    J Clin Endocrinol Metab; 1986 Mar; 62(3):484-90. PubMed ID: 3080463
    [Abstract] [Full Text] [Related]

  • 2. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children.
    Huseman CA, Hassing JM.
    J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440
    [Abstract] [Full Text] [Related]

  • 3. Growth enhancement by dopaminergic therapy in children with intrauterine growth retardation.
    Huseman CA.
    J Clin Endocrinol Metab; 1985 Sep; 61(3):514-9. PubMed ID: 3926809
    [Abstract] [Full Text] [Related]

  • 4. Use of combined Gn-RH agonist and hGH therapy for better attining the goals in precocious puberty treatment.
    Tatò L, Saggese G, Cavallo L, Antoniazzi F, Corrias A, Pasquino AM, Cisternino M.
    Horm Res; 1995 Sep; 44 Suppl 3():49-54. PubMed ID: 8719441
    [Abstract] [Full Text] [Related]

  • 5. Changes in serum immunoreactive and bioactive growth hormone concentrations in boys with advancing puberty and in response to a 20-hour estradiol infusion.
    Cemeroglu AP, Barkan AL, Kletter GB, Beitins IZ, Foster CM.
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2166-71. PubMed ID: 9215289
    [Abstract] [Full Text] [Related]

  • 6. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
    Bercu BB, Root AW, Shulman DI.
    J Clin Endocrinol Metab; 1986 Oct; 63(4):968-73. PubMed ID: 3018032
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency.
    Gelato MC, Malozowski S, Caruso-Nicoletti M, Ross JL, Pescovitz OH, Rose S, Loriaux DL, Cassorla F, Merriam GR.
    J Clin Endocrinol Metab; 1986 Jul; 63(1):174-9. PubMed ID: 3086356
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion.
    Bercu BB, Shulman D, Root AW, Spiliotis BE.
    J Clin Endocrinol Metab; 1986 Sep; 63(3):709-16. PubMed ID: 3525601
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.
    Chanoine JP, Vanderschueren-Lodeweyckx M, Maes M, Thiry-Counson G, Craen M, Van Vliet G.
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1269-75. PubMed ID: 1955508
    [Abstract] [Full Text] [Related]

  • 10. Serum luteinizing hormone and follicle-stimulating hormone and the response to luteinizing hormone-releasing factor in children and adolescents with isolated growth hormone deficiency.
    Cohen HN, Kaplan SL, Grumbach MM.
    J Clin Endocrinol Metab; 1983 Oct; 57(4):855-8. PubMed ID: 6411756
    [Abstract] [Full Text] [Related]

  • 11. High serum sex hormone-binding globulin (SHBG) and low serum non-SHBG-bound testosterone in boys with idiopathic hypopituitarism: effect of recombinant human growth hormone treatment.
    Belgorosky A, Martinez A, Domene H, Heinrich JJ, Bergada C, Rivarola MA.
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1107-11. PubMed ID: 3680477
    [Abstract] [Full Text] [Related]

  • 12. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy.
    Barreca A, Bozzola M, Cesarone A, Steenbergh PH, Holthuizen PE, Severi F, Giordano G, Minuto F.
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Urinary human growth hormone measurement using a highly sensitive sandwich enzyme immunoassay: diagnostic and therapeutic uses in patients with growth hormone deficiency.
    Kohno H, Murakami Y, Kodaira T.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1496-500. PubMed ID: 2229307
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature.
    Lampit M, Hochberg Z.
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3573-7. PubMed ID: 12161476
    [Abstract] [Full Text] [Related]

  • 18. Results of 1-year growth hormone (GH)-releasing hormone-(1-44) treatment on growth, somatomedin-C, and 24-hour GH secretion in six children with partial GH deficiency.
    Rochiccioli PE, Tauber MT, Coude FX, Arnone M, Morre M, Uboldi F, Barbeau C.
    J Clin Endocrinol Metab; 1987 Aug; 65(2):268-74. PubMed ID: 3110202
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature.
    Rogol AD, Blizzard RM, Johanson AJ, Furlanetto RW, Evans WS, Rivier J, Vale WW, Thorner MO.
    J Clin Endocrinol Metab; 1984 Oct; 59(4):580-6. PubMed ID: 6434572
    [Abstract] [Full Text] [Related]

  • 20. Effects of human growth hormone administration on growth rate and growth-stimulating activity of serum, measured by lymphocyte bioassay in hypopituitary children.
    Bozzola M, Lorini R, Schimpff RM, Severi F, Job JC.
    Horm Metab Res; 1986 Apr; 18(4):264-7. PubMed ID: 3710421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.